2006 Annual Meeting | Update on Endovascular Treatment of Cerebrovascular Diseases

Date Monday 04/03/06

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Hamza I. Maqsood, MD

Topic(s)

Learning Objectives Upon completion:
Participants should be able to understand the implications of new information derived from clinical trials pertaining to endovascular treatment for cerebrovascular diseases; effectively identify patients with cerebrovascular diseases that could potentially benefit from endovascular treatment; and understand and implement preoperative and postoperative care to patients undergoing endovascular treatment for cerebrovascular diseases.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Academician, Resident, Other

Event Timeline
02:00 PM - 02:25 PM		Techniques for Endovascular Treatment of Acute Ischemic Stroke Hamza I. Maqsood, MD
02:25 PM - 02:50 PM		Endovascular Treatment for Acute Ischemic Stroke - Selection of Patients Jose I. Suarez, MD, FAAN
02:50 PM - 03:15 PM		Angioplasty and Stent Placement for Extracranial Carotid Stenosis - Selection of Candidates for Endarterectomy, Stenting, or Medical Therapy Alex B. Chebl, MD
03:15 PM - 03:30 PM		Break
03:30 PM - 03:55 PM		Results of Recent Clinical Trials Evaluating Carotid Artery Angioplasty and Stenting Lawrence R. Wechsler, MD, FAAN
03:55 PM - 04:20 PM		Angioplasty and Stent Placement for Intracranial Stenosis Jawad F. Kirmani, MD
04:20 PM - 04:45 PM		Endovascular Treatment of Arteriovenous Malformation Italo Linfante, MD
04:45 PM - 05:10 PM		Update on Treatment of Intracranial Aneurysms Using Endovascular Modality Osama O. Zaidat, MD, FAAN
05:10 PM - 06:00 PM		Discussion

Faculty Disclosures
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Jose I. Suarez, MD, FAAN	Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic.
Italo Linfante, MD	Dr. Linfante has received personal compensation for serving as an employee of medtronic. Dr. Linfante has received personal compensation for serving as an employee of stryker. Dr. Linfante has received personal compensation for serving as an employee of cerenovus. Dr. Linfante has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for medtronic. Dr. Linfante has received stock or an ownership interest from InNeuroCO. Dr. Linfante has received stock or an ownership interest from Stryker/Surpass.
Osama O. Zaidat, MD, FAAN	Dr. Zaidat has nothing to disclose.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Alex B. Chebl, MD	No disclosure on file

��ɫ��

��ɫ��